Protalix BioTherapeutics (PLX) Gross Margin Growth (3y) (2013 - 2026)
Protalix BioTherapeutics (PLX) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Protalix BioTherapeutics | 189.97 Mn | 149.31 Mn | 12.13 Mn | -2,148.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,148.00 |
| Mar 31, 2026 | 1,995.00 |
| Dec 31, 2025 | -2,282.00 |
| Sep 30, 2025 | 325.00 |
| Jun 30, 2025 | 920.00 |
| Mar 31, 2025 | -4,337.00 |
| Dec 31, 2024 | 1,549.00 |
| Sep 30, 2024 | -1,591.00 |
| Jun 30, 2024 | 346.00 |
| Mar 31, 2024 | -2,733.00 |
| Dec 31, 2023 | -7,034.00 |
| Sep 30, 2023 | -2,072.00 |
| Jun 30, 2023 | -87.00 |
| Mar 31, 2023 | -1,635.00 |
| Dec 31, 2022 | -671.00 |
| Sep 30, 2022 | -2,738.00 |
| Jun 30, 2022 | -2,469.00 |
| Mar 31, 2022 | -1,792.00 |
| Dec 31, 2021 | 9,290.00 |
| Sep 30, 2021 | 25,842.00 |